Chemical formula: C₂₃₀H₃₂₀N₆₃O₁₂₅P₁₉S₁₉ Molecular mass: 7,162.04 g/mol
Volanesorsen is an antisense oligonucleotide designed to inhibit the formation of apoC-III, a protein that is recognised to regulate both triglyceride metabolism and hepatic clearance of chylomicrons and other triglyceride-rich lipoproteins.
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| WAYLIVRA Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Volanesorsen is an active ingredient of these brands:
Austria (AT)
Estonia (EE)
France (FR)
Ireland (IE)
Lithuania (LT)
Poland (PL)
Romania (RO)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
